Abeona Therapeutics Inc. · NASDAQ:ABEO
Nantahala Capital Management, LLC reported a 9.99% stake in Abeona Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Nantahala Capital Management, LLC reported a 9.99% stake in Abeona Therapeutics Inc., 5,775,350 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 5,775,350
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 5,775,350 |
| Wilmot B. Harkey | 9.99% | 5,775,350 |
| Daniel Mack | 9.99% | 5,775,350 |
Source
Related
- Abeona Therapeutics Inc.
- Nantahala Capital Management, LLC
- Abeona Therapeutics Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Oct 6, 2025
- Schedule 13G/A · Nantahala Capital Management, LLC · May 15, 2025
- Schedule 13D · James Russell Revocable Trust · Oct 23, 2026
- Form 4 · Seshadri Vishwas · Sep 29, 2026
- Form 4 · Vazzano Joseph Walter · Sep 29, 2026
- Form 4 · O'Malley Brendan M. · Sep 29, 2026
- Form 4 · Vasanthavada Madhav · Sep 29, 2026